Microneedle-assisted genome editing: A transdermal strategy of targeting
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
22
09
2020
accepted:
26
01
2021
entrez:
11
3
2021
pubmed:
12
3
2021
medline:
19
4
2022
Statut:
epublish
Résumé
We report a dissolvable microneedle (MN) patch that can mediate transdermal codelivery of CRISPR-Cas9-based genome-editing agents and glucocorticoids for the effective treatment of inflammatory skin disorders (ISDs). The MN is loaded with polymer-encapsulated Cas9 ribonucleoprotein (RNP) targeting
Identifiants
pubmed: 33692106
pii: 7/11/eabe2888
doi: 10.1126/sciadv.abe2888
pmc: PMC7946375
pii:
doi:
Substances chimiques
NLR Family, Pyrin Domain-Containing 3 Protein
0
Nlrp3 protein, mouse
0
Polymers
0
Ribonucleoproteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Références
Mol Ther. 2020 Jun 3;28(6):1432-1441
pubmed: 32348718
Int J Nanomedicine. 2019 Jul 30;14:5849-5863
pubmed: 31440050
An Bras Dermatol. 2016 Sep-Oct;91(5):566-578
pubmed: 27828627
Int J Pharm. 2018 May 5;542(1-2):213-220
pubmed: 29551748
Clin Exp Allergy. 2018 Sep;48(9):1080-1091
pubmed: 29900602
Nat Commun. 2018 Oct 5;9(1):4092
pubmed: 30291237
Eur J Immunol. 2017 Jul;47(7):1096-1107
pubmed: 28555727
J Dermatol Sci. 2015 May;78(2):89-94
pubmed: 25771165
J Dermatol Sci. 2020 Jun;98(3):146-151
pubmed: 32173167
N Engl J Med. 2008 Apr 3;358(14):1483-94
pubmed: 18385500
Nat Rev Dis Primers. 2016 Nov 24;2:16082
pubmed: 27883001
J Dermatol Sci. 2015 Nov;80(2):89-93
pubmed: 26341698
N Engl J Med. 2009 Jul 30;361(5):496-509
pubmed: 19641206
Nat Genet. 2015 Jun;47(6):607-14
pubmed: 25938942
Sci Adv. 2020 Jul 31;6(31):eabb5274
pubmed: 32923608
ACS Nano. 2018 Jul 24;12(7):6904-6916
pubmed: 29949348
J Eur Acad Dermatol Venereol. 2018 May;32(5):654-655
pubmed: 29676533
Food Chem Toxicol. 2019 Jun;128:223-232
pubmed: 30946874
Front Pharmacol. 2015 Nov 05;6:262
pubmed: 26594174
Int Immunopharmacol. 2019 Sep;74:105682
pubmed: 31203155
Mol Cell Oncol. 2015 Nov 11;3(1):e1065947
pubmed: 27308575
J Immunol. 2016 Sep 15;197(6):2421-33
pubmed: 27521339
Eur J Pharmacol. 2018 Oct 5;836:57-66
pubmed: 30125561
J Control Release. 2020 Feb;318:210-222
pubmed: 31843640
Nat Biomed Eng. 2019 Oct;3(10):806-816
pubmed: 31332341
Chem Rev. 2017 Aug 9;117(15):9874-9906
pubmed: 28640612
J Dermatol Sci. 2017 Dec;88(3):357-364
pubmed: 29017796
J Control Release. 2016 Oct 10;239:182-202
pubmed: 27381248
ACS Nano. 2019 Apr 23;13(4):4354-4360
pubmed: 30942567
J Control Release. 2020 Jun 10;322:236-247
pubmed: 32169537
J Exp Med. 2017 Nov 6;214(11):3219-3238
pubmed: 29021150
Sci Adv. 2019 Jun 12;5(6):eaaw8922
pubmed: 31206027
Nat Rev Immunol. 2016 Jul;16(7):407-20
pubmed: 27291964
Nat Rev Dis Primers. 2018 Jun 21;4(1):1
pubmed: 29930242